According to Future Market Insights, in 2025, the laminating adhesives market was valued at approximately USD 3,936.31 ...

The transaction is expected to close on or about July 28, 2025, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering to fund ...

Johnson said he was hiring a new CEO and CTO, he added, "who can lead the business while I focus on don't die." ...

The company seeks to accelerate drug development by automating analysis of study samples.

Kristin Cabot, Chief People Officer of Astronomer, is facing mounting criticism after an old LinkedIn bio resurfaced in the wake of the company's now-infamous 'kiss cam' scandal. The phrase, 'I lead ...

Syntis Bio, Inc. (Syntis), a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes and rare diseases, announced today ...

—Neopharmed Gentili will pay BioCryst $250 million upfront for the European assets and rights related to ORLADEYO, and up to $14 million in future milestones— —BioCryst plans to use proceeds to retire ...